本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Allogene Therapeutics Inc.

1.78
+0.02001.14%
盤後1.77-0.0090-0.51%19:52 EDT
成交量:389.44萬
成交額:693.72萬
市值:6.14億
市盈率:-2.73
高:1.81
開:1.80
低:1.75
收:1.76
52周最高:4.46
52周最低:1.04
股本:3.45億
流通股本:2.62億
量比:0.67
換手率:1.49%
股息:- -
股息率:- -
每股收益(TTM):-0.6510
每股收益(LYR):-0.8652
淨資產收益率:-42.39%
總資產收益率:-22.08%
市淨率:1.41
市盈率(LYR):-2.06

資料載入中...

2024/03/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/14

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/14

重要事件披露

Form 8-K - Current report
2024/03/14

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/02/23

SEC問詢函

Form CORRESP - Correspondence
2024/02/16

重要事件披露

Form 8-K - Current report
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/05

重要事件披露

Form 8-K - Current report
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/16

SEC問詢函

Form CORRESP - Correspondence
2023/11/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/02

重要事件披露

Form 8-K - Current report
2023/10/26

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/18

重要事件披露

Form 8-K/A - Current report: [Amend]